Foghorn Therapeutics Inc(NASDAQ:FHTX) 
Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug tar...
Website: http://www.foghorntx.com
Founded: 2015
CEO: Adrian Gottschalk
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 3.15
H 3.78
L 3.10
C 3.44
V 292,889
10EMA 3.44
20EMA 3.44
60EMA 3.44
120EMA 3.44
250EMA 3.44